Ramipril improved walking times and QOL in peripheral artery disease and intermittent claudication Ahimastos AA, Walker PJ, Askew C, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA. 2013;309:453-60. Clinical impact rating: F ★★★★★★✩ Question In patients with peripheral artery disease (PAD) and intermittent claudication, what is the efficacy of ramipril for walking performance and quality of life
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.